CATALYST BIOSCIENCES INC (CBIO) Stock Analyst Ratings
NASDAQ:CBIO - Nasdaq - US14888D2080 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 43% to CBIO. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 16.32. This target is 3091.86% above the current price.
CBIO was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about CBIO.
In the previous month the buy percentage consensus was at a similar level.
CBIO was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2021-11-15 | Raymond James | Downgrade | Outperform -> Market Perform |
| 2021-08-06 | Raymond James | Maintains | Outperform |
| 2021-04-29 | Raymond James | Maintains | Outperform |
| 2021-02-10 | Piper Sandler | Initiate | Overweight |